An observational study in Enamel Erosion, sponsored by Procter and Gamble. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-05.
Sponsored by Procter and Gamble · Observational
The aim of this 5 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices to assess enamel erosion protection in-situ using surface profilometry.
Procter and Gamble is the lead sponsor of 80 studies on the registry; none are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 10 (100%) have results posted.
Counted across the registry records on this site, refreshed daily.
This meta-analysis includes healthy adult male and females.
Inclusion Criteria:
Twice daily use
Drug: Stannous fluoride dentifrice
Twice daily use
Drug: Positive control dentifrice
Twice daily use
Drug: Negative control dentifrice
Stannous fluoride (0.454%) dentifrice
Positive control dentifrice containing potassium nitrate or arginine.
Negative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%)
Change from Baseline Surface profilometry
Enamel samples will be measured via profilometry after 10 days of study use.
Time frame: 10 days
This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Procter and Gamble